News

CHICAGO — Finerenone prevented new-onset atrial fibrillation or flutter in patients with chronic ... 2.2-3.5), a composite kidney outcome (aHR = 2; 95% CI, 1.4-2.7) and all-cause death (aHR ...
Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...
Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 ...
During a live event, Shuo Ma, MD, PhD, discussed the outcomes of the BRUIN trial of pirtobrutinib in BTK inhibitor–pretreated ...
Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...
AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AccurECGTM software platform has been ...
Pulsed field ablation (PFA) technology made some advances with 12-month results for the Globe Pulsed Field System in ...
New research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need ...
Although a history of 2 spontaneous episodes of AF or atrial flutter was an entry criterion ... by the 118 patients are shown in Figure 1. Sixty-eight percent of the episodes were detected as ...
New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of ...
Pulsed field ablation (PFA) technology made some advances with 12-month results for the Globe Pulsed Field System in paroxysmal atrial fibrillation ... required only 1.2 applications for PVI ...